Page results
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
File results
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0772 - Treatments for rare diseases
-
FOI/2022/0774 - Pre-pregnancy counselling clinics with consultant-led maternity units for women with medical problems
-
FOI/2022/0775 - Data on COVID-19 infections and related illness in staff
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0782 - Digital dictation, voice recognition software and outsourced transcription services
-
FOI/2022/0783 - Separate units/ beds allocated for delivery of CAR-T therapy and BMT services
-
FOI/2022/0785 - Patient treatment with Nivolumab